iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

15/07/2021 - 08:00 | Portfolio

World-leading surgeons to join iSTAR Medical’s STAR-V study WAVRE, Belgium — 15 July 2021: iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemption (IDE) to start a pivotal trial with MINIjectTM. The STAR-V study will investigate MINIjectTM […]

Read all news
PDF File (167.88 KB)